TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Awareness of PrEP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical activity (aerobic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity (strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in blood THC-COOH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in blood THC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in cannabis use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Montgomery-Asberg Depression Rating Scale (MADRS-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of patients requiring shunt surgery
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of patients progressing to symptomatic iNPH
Endpoint domain: Mortality/survival
Primary endpoint: Post operative improvement in iNPH-scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adolescent Occupational Balance Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Teenage Executive Functioning Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Internet Gaming Disorder Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy of moderate/severe acute gastroenteritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Childhood Autism Rating Scores (CARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RP2D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of peripheral and central inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EEG physiological detection index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Biofilm formation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of subjects with a Methemoglobin >5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CVD risk level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total Lesion Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SV2A density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of caregivers who participate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change From Baseline in Corneal Fluorescein Staining (CFS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Eye Dryness Symptom (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline of activity-related joint discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Acute FFR collateral change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Late FFR collateral change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute MLD change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Late MLD change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DRSS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functionality in gait
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EAT-Lancet Index score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of brain metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent susceptibility to each drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Putamen node strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence to opioid agonist treatment (OAT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in PROMIS 6-item Pain Interference Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: clinical characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in St George's Respiratory Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Demoralization
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mystical Experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Challenging Experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oral status of children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in measure of the Belief in Controlling Weight scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in measure of the Belief in Controlling Lifestyle scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in frequency of cataplexy attacks from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Recrudescence of dysphagia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Anti-Müllerian hormone (AMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Tactile localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKDC subjective evaluation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Range on motion (ROM) of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Women Referred that are Consented
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attrition as a Function of Time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent of Scheduled Assessments Completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of LP-168
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Life Quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cognitive Capacity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Area under the receiver operating characteristic curve (ROC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported outcomes (PRO) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Borg Category-Ratio 0-10 Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of E7 T-Cell Receptor Induction Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tampa Kinesiophoby Scoring
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change from baseline impression of movement at day 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change from baseline nature of this impression at day 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change from baseline intensity of the movement felt at day 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Device wear time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in attitudes towards older adults with physical disabilities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number and percentage of participants with unsolicited and safety laboratory-based adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Abstinence from Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective cognitive impairment based on cognitive failure questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Objective cognitive performance based on a composite score for executive functions from the CANTAB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Basic Resuscitation Skills Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and percentage of participants with any AE
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of participants with clinically significant changes from baseline in Vital Sign Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Concentration-Time Curve of AZD9550 following repeat weekly SC doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Fidelity (to Student Intervention Plan) at 3 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Alignment (of Student Intervention Plan) at 3 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety laboratory tests associated with AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of signs and symptoms associated with AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in the Symbol Digit Modalities Test (SDMT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hemoglobin A1c (HbA1c) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success rate of a primary molar pulpotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic success of a primary molar pulpotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function (Forced vital capacity (FVC))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary function (Forced expiratory volume in the first second (FEV1))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 30-days all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Width and height of the alveolar ridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Participants Who Have an Individual Counseling Session About PrEP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cough-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diabetes Knowledge Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Efficacy Scale in Gestational Diabetes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Supporting Nasopharyngeal Airway (ssNPA) tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the nature and severity of insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in FEV1 AUC0-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Personal Health Questionnaire-8 item (PHQ8)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients prescribed initial antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Response Magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Trimethoprim Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to Trimethoprim Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post operative IOL tilt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of total antioxidants (TAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of lipid peroxidation products (TBARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tumor necrosis factor (TNF α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Investigator Assessment of Global Improvement (IAGI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PJI diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Satisfaction With Anesthesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective cure rate of prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Remdesivir treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcriptome differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inadvertent dislodgement of other intracranial monitoring device/s
Endpoint domain: Adverse events/effects
Primary endpoint: Skin changes associated with TCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: modified Harris Hip Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain on Short Form McGill Questionnaire 2 (SFMPQ-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in disability on the Roland Morris Disability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Quality of life on the WHOQOL BREF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total success rate of tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in anterior chamber angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Healing process of venous leg ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of HPV+ sperm samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in full mouth plaque score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-Efficacy for Managing Chronic Disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Standardized uptake value (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Target-to-background ratio (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Rocatinlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve (AUC) From Time Zero to Time of Last Quantifiable Concentration (AUClast) of Rocatinlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC From Time Zero to Infinity (AUCinf) of Rocatinlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reference range interval of PSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the severity of grief symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in basophil activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in skin prick test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pathologic complete response (PCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-minute Walk Test (6MWT) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise pressor response (EPR) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intramuscular maximal bioenergetics (Vmax) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epicardial adipose tissue measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Repetitions in the 1-minute sit-to-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Subcutaneous infliximab treatment in clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of subcutaneous infliximab treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of adherent patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Care gap order rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Level of mechanical energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of ensemble model for early GC detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Program Adherence Rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction of Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection rates for colorectal adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of completed telemedicine visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to study drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EQ-5D-5L score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postspinal hypotension detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ5D3L one week after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bone Gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wake Forest Physician Trust Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First-pass complete recanalization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference of expiratory volume in 1 s (SEV1) and tidal volume (TV) between the left and right lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in expiratory volume in 1 s (SEV1) and tidal volume (TV) for the anterior-posterior, inferior-superior and medial-lateral lung regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of gut Microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Metabolic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Velocity of gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grading Diabetic Retinopathy Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisional Hernia at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisional Hernia at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement with Guide
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nutrition behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction with Granisetron Transdermal Delivery System (GTDS) versus Ondansetron pill
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spine Correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cerebral nicotinamide adenine dinucleotide (NAD) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrospinal fluid (CSF) NAD and related metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral metabolism patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD47 expression level on platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six Minute Walk test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase 2 dose (RP2D) of Senza5 CART5 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: survival (days)
Endpoint domain: Mortality/survival
Primary endpoint: Difference in meters walked in 6MWTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes distress scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eating Disorder Examination Questionnaire (EDE-Q 6.0)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status